© 1995 Oxford University Press
research-article |
Influenza Vaccine Effectiveness in Preventing Hospitalization among the Elderly during Influenza Type A and Type B Seasons
*Department of Epidemiology, School of Public Health, University of Michigan 109 Observatory, Ann Arbor, MI 48109-2029, USA
Department of Population Planning and International Health, University of Michigan USA
BACKGROUND: Influenza vaccine effectiveness evaluations were carried out among the elderly, as part of a demonstration established to estimate the value of including influenza vaccination as a covered Medicare benefit.
METHODS: Cases hospitalized with pneumonia and influenza-related diagnoses during November through April were identified and group matched to randomly selected community controls. Data were collected from cases and controls on influenza vaccination status and other factors which could have confounded the association between vaccination and hospitalization. A community-based influenza surveillance programme was conducted each year to determine the timing and aetiology of influenza activity. Logistic regression analyses were carried out to evaluate the association of influenza vaccination with the likelihood of hospitalization.
RESULTS: In 1990–1991, during the peak of the influenza type B outbreak, Influenza vaccination was estimated to be 31% (95% Cl: 4–51%) effective in reducing the likelihood of hospitalization. In 1991–1992, during the peak of the influenza type A (H3N2) epidemic, a nearly identical point estimate for vaccine effectiveness was demonstrated (32%, 95% Cl: 7–50%), Identical analyses carried out each year during the periods of low or absent influenza activity failed to demonstrate a significant effect for vaccination in preventing hospitalization.
CONCLUSION: Results indicated that a significant benefit for vaccination could be expected during both type A and type B influenza seasons.
Keywords aged, chronic health conditions, effectiveness, elderly, hospitalization, influenza, influenza vaccination, pneumonia, influenza
Revised 1 May 1995
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. A Jackson, M. L Jackson, J. C Nelson, K. M Neuzil, and N. S Weiss Evidence of bias in estimates of influenza vaccine effectiveness in seniors Int. J. Epidemiol., April 1, 2006; 35(2): 337 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Monto Invited Commentary: Use of Selective Viral Cultures to Adjust Nonvirologic Endpoints in Studies of Influenza Vaccine Efficacy Am. J. Epidemiol., August 15, 2003; 158(4): 312 - 315. [Full Text] [PDF]
|
|
|
|
|
|
E. Hak, A. W. Hoes, D. E. Grobbee, J. W. J. Lammers, G. A. van Essen, A. M. van Loon, and T. J. M. Verheij Conventional Influenza Vaccination Is Not Associated with Complications in Working-Age Patients with Asthma or Chronic Obstructive Pulmonary Disease Am. J. Epidemiol., April 15, 2003; 157(8): 692 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Nichol, J. Nordin, J. Mullooly, R. Lask, K. Fillbrandt, and M. Iwane Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly N. Engl. J. Med., April 3, 2003; 348(14): 1322 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Hak, T. J M Verheij, D E Grobbee, K L Nichol, and A W Hoes Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications J Epidemiol Community Health, December 1, 2002; 56(12): 951 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. McElhaney Guest Editorial: Influenza: A Preventable Lethal Disease J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2002; 57(10): M627 - 628. [Full Text] [PDF]
|
|
|
|
|
|
A. S. Monto, K. Hornbuckle, and S. E. Ohmit Influenza Vaccine Effectiveness among Elderly Nursing Home Residents: A Cohort Study Am. J. Epidemiol., July 15, 2001; 154(2): 155 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Stephenson and K.G. Nicholson Influenza: vaccination and treatment Eur. Respir. J., June 1, 2001; 17(6): 1282 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lalezari, K. Campion, O. Keene, and C. Silagy Zanamivir for the Treatment of Influenza A and B Infection in High-Risk Patients: A Pooled Analysis of Randomized Controlled Trials Arch Intern Med, January 22, 2001; 161(2): 212 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Nichol, L. Baken, J. Wuorenma, and A. Nelson The Health and Economic Benefits Associated With Pneumococcal Vaccination of Elderly Persons With Chronic Lung Disease Arch Intern Med, November 8, 1999; 159(20): 2437 - 2442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Nichol, L. Baken, and A. Nelson Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease Ann Intern Med, March 2, 1999; 130(5): 397 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Nichol, J. Wuorenma, and T. von Sternberg Benefits of Influenza Vaccination for Low-, Intermediate-, and High-Risk Senior Citizens Arch Intern Med, September 14, 1998; 158(16): 1769 - 1776. [Abstract] [Full Text] [PDF]
|
|